Trials / Unknown
UnknownNCT03344237
hsTnT in Patients Admitted to the ED With Atrial Fibrillation in the Era of NOACs - Heidelberg Registry of Atrial Fibrillation
High-Sensitivity Cardiac Troponin T in Patients Admitted to the Emergency Department With Atrial Fibrillation in the Era of Novel Oral Anticoagulants - Heidelberg Registry of Atrial Fibrillation
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,000 (estimated)
- Sponsor
- University Hospital Heidelberg · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- —
Summary
The purpose of the Heidelberg Registry of Atrial Fibrillation (HERA-FIB) is to collect data on the prevalence and clinical significance of elevated cardiac troponin in a large registry of unselected patients with atrial fibrillation presenting to an emergency department in the era of novel oral anticoagulants (NOACs).
Conditions
Timeline
- Start date
- 2017-09-14
- Primary completion
- 2019-11-01
- Completion
- 2020-03-01
- First posted
- 2017-11-17
- Last updated
- 2019-09-27
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03344237. Inclusion in this directory is not an endorsement.